The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Malyavin A.G.

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Belotserkovskaya Yu.G.

Russian Medical Academy of Continuing Professional Education

Bolieva L.Z.

North Ossetian State Medical Academy of the Ministry of the Healthcare of the Russian Federation

Vershinina M.V.

OLLA-MED;
M.F. Vladimirskiy Moscow Regional Research Clinical Institute

Zhuravleva M.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University);
Scientific Centre of Medical Application Expertise of the Ministry of the Healthcare of the Russian Federation

Zaitsev A.A.

Main Military Clinical Hospital named after academician N.N. Burdenko of the Ministry of defense of the Russian Federation;
Russian Biotechnological University (Moscow State University of Food Production)

Leshchenko I.V.

Ural State Medical University of the Ministry of the Healthcare of the Russian Federation

Sinopalnikov A.I.

Russian Medical Academy of Continuous Professional Education under The Ministry of Health of the Russian Federation

Fesenko O.V.

Russian Medical Academy of Continuing Professional Education

Esaulova N.A.

Ural State Medical University of the Ministry of the Healthcare of the Russian Federation

Practical aspects of the application of a new drug combination of ambroxol+guaiphenesine+ levosalbutamol in the treatment of acute bronchitis in adults. Experts council resolution

Authors:

Malyavin A.G., Belotserkovskaya Yu.G., Bolieva L.Z., Vershinina M.V., Zhuravleva M.V., Zaitsev A.A., Leshchenko I.V., Sinopalnikov A.I., Fesenko O.V., Esaulova N.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2023;26(6): 108‑112

Read: 1994 times


To cite this article:

Malyavin AG, Belotserkovskaya YuG, Bolieva LZ, et al. . Practical aspects of the application of a new drug combination of ambroxol+guaiphenesine+ levosalbutamol in the treatment of acute bronchitis in adults. Experts council resolution. Russian Journal of Preventive Medicine. 2023;26(6):108‑112. (In Russ.)
https://doi.org/10.17116/profmed202326061108

References:

  1. Pul'monologiya. Nacional'noe rukovodstvo. Kratkoe izdanie. Pod red. AG Chuchalina. M.: GEOTAR-Media, 2013. (In Russ.).
  2. Albert R. Diagnosis and treatment of acute bronchitis. American Family Physician. 2010;82(11):1345-1350.
  3. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections — full version. Clinical Microbiology and Infection. 2011;17 Suppl 6(Suppl 6):E1-E59.  https://doi.org/10.1111/j.1469-0691.2011.03672.x
  4. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. The Cochrane Database of Systematic Reviews. 2004;(4):CD000245.
  5. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UBS, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Hammond CS, Tarlo SM. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):1S-23S.  https://doi.org/10.1378/chest.129.1_suppl.1S
  6. Ostryj bronhit u vzroslyh. Proekt klinicheskih rekomendacij Ministerstva Zdravoohraneniya Rossijskoj Federacii. 2022. Accessed May 31, 2023. (In Russ.). https://spulmo.ru/upload/kr/OB_2022.pdf
  7. Pomortseva IV, Mikhailov IB. Pathophysiological and pharmacological concepts in the treatment of bronchopulmonary diseases. Meditsinskiy Sovet. 2022;16(19):79-86. (In Russ.). https://doi.org/10.21518/2079-701X-2022-16-19-79-86
  8. Shmeleva NM. The use of the combined mucoregulator Ascoril in diseases of the respiratory system. RMJ. 2012;(34):1671-1677. Accessed May 31, 2023. (In Russ.). https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Primenenie_kombinirovannogo_mukoregulyatora_Askoril_pri_zabolevaniyah_organov_dyhaniya/
  9. Klyachkina IL. Early treatment of a cold — prevention of post-infectious cough. RMJ. 2016;(16):1051-1058. Accessed May 31, 2023. (In Russ.). https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Rannee_lechenie_prostudy__profilaktika_postinfekcionnogo_kashlya/
  10. Prabhu Shankar S, Chandrashekharan S, Bolmall CS, Baliga V. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study. Journal of the Indian Medical Association. 2010;108(5):313-320. 
  11. Ovchinnikov AYu, Panyakina MA, Korostelev SA, Mityuk AM. The therapeutic modalities for the management of cough associated with acute respiratory viral infection used in the practical work of an otolaryngologist. Vestnik otorinolaringologii. 2014;(2):86-89. (In Russ.).
  12. Grigorieva NYu. Evaluation of the clinical efficacy and safety of the bined drug Ascoril in patients with comorbid bronchopulmonary and cardiovascular pathology. RMJ. 2013;(29):1475-1479. (In Russ.).
  13. Klyachkina IL. Treatment of cough with SARS and influenza. RMJ. 2012; (6):278-285. Accessed May 31, 2023. (In Russ.).
  14. Leshchenko IV, Esaulova NA. The results of an observational study evaluating the treatment of patients with productive cough after COVID-19. RMJ. 2023;1:6-11. (In Russ.).
  15. Zaitsev AA, Okovityi SV, Kryukov EV. Modern potentials of mucoactive therapy. Pharmateka. 2015;14:81-4. Accessed May 31, 2023. (In Russ.). https://pharmateca.ru/ru/archive/article/31934.Accessed:25.01.2023
  16. Lidzhieva AA, Smolyarehuk EA. Levosalbutamol and new opportunities for the treatment of bronchial asthma (review of the related studies). Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya. 2015;2:25-8. (In Russ.).
  17. Miroshnichenko AG, Bulgakova YS, Perfiliev VY, Bazarnova NG. Levosalbutamol as alternative to drugs on the basis of racemic salbutamol: Review of the results of pre-clinical research. Regulatory Mechanisms in Biosystems. 2017;8(4):583-595. (In Russ.). https://doi.org/10.15421/021790
  18. Zaitsev AA, Leshchenko IV, Esaulova NA, Viktorova IA. Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis. Terapevticheskii arkhiv. 2023;95(3):235-241. (In Russ.). https://doi.org/10.26442/00403660.2023.03.202099

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.